To what extent can the in vivo CRISPR editing of metabolic disease help prevent obesity and type 2 diabetes?

Created using ChatSlide

This presentation explores the integration of CRISPR technology and machine learning (ML) to revolutionise genome editing, particularly in preventing diseases such as metabolic disorders. It covers evolutionary breakthroughs of CRISPR, its application to metabolic diseases, and challenges in delivering CRISPR in vivo. The presentation highlights innovations like optimising guide RNA and enhancing specificity through AI. Key sections compare current treatments against CRISPR's advantages,...